BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20682661)

  • 1. Influence of CD40 rs1883832 polymorphism in susceptibility to and clinical manifestations of biopsy-proven giant cell arteritis.
    Rodríguez-Rodríguez L; Castañeda S; Vázquez-Rodríguez TR; Morado IC; Marí-Alfonso B; Gómez-Vaquero C; Miranda-Filloy JA; Narvaez J; Ortego-Centeno N; Blanco R; Fernández-Gutiérrez B; Martín J; González-Gay MA
    J Rheumatol; 2010 Oct; 37(10):2076-80. PubMed ID: 20682661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
    Martin J; Perez-Armengol C; Miranda-Filloy JA; Vilchez JR; Lopez-Nevot MA; Garcia-Porrua C; Gonzalez-Gay MA
    J Rheumatol; 2006 Feb; 33(2):285-8. PubMed ID: 16465659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between intercellular adhesion molecule-1 gene polymorphisms and giant cell arteritis.
    Amoli MM; Shelley E; Mattey DL; Garcia-Porrua C; Thomson W; Hajeer AH; Ollier WE; Gonzalez-Gay MA
    J Rheumatol; 2001 Jul; 28(7):1600-4. PubMed ID: 11469468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis.
    Carmona FD; Rodríguez-Rodríguez L; Castañeda S; Miranda-Filloy JA; Morado IC; Narváez J; Marí-Alfonso B; Unzurrunzaga A; Ríos-Fernández R; Blanco R; de Miguel E; Martín J; González-Gay MA
    Hum Immunol; 2011 May; 72(5):458-61. PubMed ID: 21354457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to biopsy-proven giant cell arteritis.
    Gonzalez-Gay MA; Oliver J; Orozco G; Garcia-Porrua C; Lopez-Nevot MA; Martin J
    J Rheumatol; 2005 Aug; 32(8):1510-2. PubMed ID: 16078327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between STAT4 gene polymorphism and biopsy-proven giant cell arteritis.
    Palomino-Morales R; Vazquez-Rodriguez TR; Morado IC; Castañeda S; Ortego-Centeno N; Miranda-Filloy JA; Lamas JR; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2009 May; 36(5):1021-5. PubMed ID: 19332627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis.
    Palomino-Morales R; Torres O; Vazquez-Rodriguez TR; Morado IC; Castañeda S; Callejas-Rubio JL; Miranda-Filloy JA; Fernandez-Gutierrez B; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2009 Jul; 36(7):1501-6. PubMed ID: 19531762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor gene polymorphisms in giant cell arteritis.
    Boiardi L; Casali B; Nicoli D; Farnetti E; Chen Q; Macchioni P; Catanoso MG; Pulsatelli L; Meliconi R; Salvarani C
    J Rheumatol; 2003 Oct; 30(10):2160-4. PubMed ID: 14528511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain.
    Palomino-Morales R; Vazquez-Rodriguez TR; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2009 Feb; 36(2):341-6. PubMed ID: 19040303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis.
    Salvarani C; Casali B; Farnetti E; Pipitone N; Formisano D; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Grazia Catanoso M; Restuccia G; Ghinoi A; Boiardi L
    Arthritis Rheum; 2007 Oct; 56(10):3502-8. PubMed ID: 17907177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis.
    Carmona FD; Serrano A; Rodríguez-Rodríguez L; Castañeda S; Miranda-Filloy JA; Morado IC; Narváez J; Solans R; Sopeña B; Marí-Alfonso B; Unzurrunzaga A; Ortego-Centeno N; Blanco R; de Miguel E; Hidalgo-Conde A; Martín J; González-Gay MA
    J Rheumatol; 2011 Dec; 38(12):2598-601. PubMed ID: 21965647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CD24 gene polymorphisms with susceptibility to biopsy-proven giant cell arteritis.
    Rueda B; Miranda-Filloy JA; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2008 May; 35(5):850-4. PubMed ID: 18381780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis.
    Rueda B; Lopez-Nevot MA; Lopez-Diaz MJ; Garcia-Porrua C; Martín J; Gonzalez-Gay MA
    J Rheumatol; 2005 Sep; 32(9):1737-41. PubMed ID: 16142870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of IL2RA rs2104286 polymorphism in the risk of biopsy-proven giant cell arteritis.
    Rodríguez-Rodríguez L; Castañeda S; Vázquez-Rodríguez TR; Morado IC; Marí-Alfonso B; Gómez-Vaquero C; Miranda-Filloy JA; Ortego-Centeno N; Narvaez J; Blanco R; Fernández-Gutiérrez B; Martín J; González-Gay MA
    J Rheumatol; 2010 Nov; 37(11):2331-3. PubMed ID: 20810507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritis.
    Gonzalez-Gay MA; Oliver J; Sanchez E; Garcia-Porrua C; Paco L; Lopez-Nevot MA; Ollier WE; Martin J
    J Rheumatol; 2005 Nov; 32(11):2178-82. PubMed ID: 16265698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis.
    Rodríguez-Rodríguez L; Castañeda S; Vázquez-Rodríguez TR; Morado IC; Gómez-Vaquero C; Marí-Alfonso B; Miranda-Filloy JA; Narvaez J; Ortego-Centeno N; Vicente EF; Blanco R; Amigo-Diaz E; Fernández-Gutiérrez B; Martin J; González-Gay MA
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S12-6. PubMed ID: 21269573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain.
    Rueda B; Roibas B; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2007 Jul; 34(7):1535-9. PubMed ID: 17552041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between IRF5 gene polymorphisms and biopsy-proven giant cell arteritis.
    Torres O; Palomino-Morales R; Vazquez-Rodriguez TR; Castañeda S; Morado IC; Miranda-Filloy JA; Valero F; Callejas-Rubio JL; Fernandez-Gutierrez B; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2010 Jan; 37(1):136-40. PubMed ID: 19918036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCP-1 gene haplotype association in biopsy proven giant cell arteritis.
    Amoli MM; Salway F; Zeggini E; Ollier WE; Gonzalez-Gay MA
    J Rheumatol; 2005 Mar; 32(3):507-10. PubMed ID: 15742444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of BANK1 gene polymorphisms in biopsy-proven giant cell arteritis.
    Torres O; Palomino-Morales R; Castañeda S; Vazquez-Rodriguez TR; Morado IC; Miranda-Filloy JA; Amigo-Diaz E; Vicente EF; Ortego-Centeno N; Fernandez-Gutierrez B; Martin J; Gonzalez-Gay MA
    J Rheumatol; 2010 Jul; 37(7):1502-4. PubMed ID: 20472928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.